Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
about
The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.Companion and complementary diagnostics for first-line immune checkpoint inhibitor treatment in non-small cell lung cancer.Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse modelsPrognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New EvidencesAnti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination StrategiesCirculating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
P2860
Q52679182-73870D8C-1DFD-41E1-B33D-30905AAA29ACQ55347820-946C5B66-6F58-42FC-9143-7A51E11BA18DQ55454963-F4D9D409-7026-42CD-BD29-E22C646D466AQ56889140-F46C6358-2B4B-4879-90DD-4EB2717E6C7EQ57191808-79F12B94-7449-46F3-A223-3FBF6A471F0DQ58795231-E70D2D5C-1AEA-4918-8F2E-8D4792375931Q58799565-675A5D83-5A1A-407C-872A-5EBEBD18838D
P2860
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
@en
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
@nl
type
label
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
@en
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
@nl
prefLabel
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
@en
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
@nl
P2093
P2860
P356
P1476
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
@en
P2093
Benjamin Levy
Josephine Feliciano
Khinh Ranh Voong
P2860
P356
10.21037/ATM.2017.06.48
P577
2017-09-01T00:00:00Z